Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 16,584Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 42BIOMARIN PHARM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SAPROPTERIN DIHYDROCHLORIDE

US Patent Number : 8067416

Drug Substance Claim :

Drug Product Claim :

Application Number : 205065

Patent Use Code : U-1589

Delist Requested :

Patent Use Description : METHOD OF USE FOR REDU...

Patent Expiration Date : 2024-11-17

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SAPROPTERIN DIHYDROCHLORIDE

US Patent Number : 7566714

Drug Substance Claim :

Drug Product Claim :

Application Number : 205065

Patent Use Code : U-1589

Delist Requested :

Patent Use Description : METHOD OF USE FOR REDU...

Patent Expiration Date : 2024-11-17

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SAPROPTERIN DIHYDROCHLORIDE

US Patent Number : RE43797

Drug Substance Claim :

Drug Product Claim :

Application Number : 22181

Patent Use Code : U-1156

Delist Requested :

Patent Use Description : TO REDUCE BLOOD PHENYL...

Patent Expiration Date : 2024-11-17

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SAPROPTERIN DIHYDROCHLORIDE

US Patent Number : 7566714

Drug Substance Claim :

Drug Product Claim :

Application Number : 205065

Patent Use Code : U-1589

Delist Requested :

Patent Use Description : METHOD OF USE FOR REDU...

Patent Expiration Date : 2024-11-17

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SAPROPTERIN DIHYDROCHLORIDE

US Patent Number : RE43797

Drug Substance Claim :

Drug Product Claim :

Application Number : 205065

Patent Use Code : U-1590

Delist Requested :

Patent Use Description : KUVAN IS INDICATED TO ...

Patent Expiration Date : 2024-11-17

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SAPROPTERIN DIHYDROCHLORIDE

US Patent Number : 7566714

Drug Substance Claim :

Drug Product Claim :

Application Number : 22181

Patent Use Code : U-989

Delist Requested :

Patent Use Description : FOR REDUCING BLOOD PHE...

Patent Expiration Date : 2024-11-17

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SAPROPTERIN DIHYDROCHLORIDE

US Patent Number : RE43797

Drug Substance Claim :

Drug Product Claim :

Application Number : 205065

Patent Use Code : U-1590

Delist Requested :

Patent Use Description : KUVAN IS INDICATED TO ...

Patent Expiration Date : 2024-11-17

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SAPROPTERIN DIHYDROCHLORIDE

US Patent Number : 9433624

Drug Substance Claim :

Drug Product Claim :

Application Number : 205065

Patent Use Code : U-1589

Delist Requested :

Patent Use Description : METHOD OF USE FOR REDU...

Patent Expiration Date : 2024-11-17

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SAPROPTERIN DIHYDROCHLORIDE

US Patent Number : 7612073

Drug Substance Claim :

Drug Product Claim :

Application Number : 205065

Patent Use Code : U-1010

Delist Requested :

Patent Use Description : TO REDUCE BLOOD PHENYL...

Patent Expiration Date : 2024-11-17

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

SAPROPTERIN DIHYDROCHLORIDE

US Patent Number : 9433624

Drug Substance Claim :

Drug Product Claim :

Application Number : 205065

Patent Use Code : U-1589

Delist Requested :

Patent Use Description : METHOD OF USE FOR REDU...

Patent Expiration Date : 2024-11-17

blank